Arq Neuropsiquiatr. 2003 Mar;61(1):146-52.
Epub 2003 Apr 16.
[Transcranial
magnetic stimulation]
[Article in Portuguese]
Conforto AB, Marie SK, Cohen LG, Scaff M.
Divisao de Clinica Neurologica, Hospital das Clinicas, Faculdade de Medicina,
Universidade de Sao Paulo, Sao Paulo, SP, Brasil.
Hum Psychopharmacol 2002 Oct;17(7):353-6
Combining
high and low frequencies in rTMS antidepressive treatment: preliminary results.
Conca A, Di Pauli J, Beraus W, Hausmann A, Peschina W, Schneider H, Konig P,
Hinterhuber H. Departments of Psychiatry I and II, Regional Hospital,
6830 Rankweil, Austria.
J Clin Neurophysiol 2002 Aug;19(4):272-93
Applications
of transcranial magnetic stimulation in movement disorders.
Cantello R.
Department of Medical Sciences, Section of Neurology, School of Medicine,
Amedeo Avogadro University, Novara, Italy.
Neuropharmacology 2002 Jul;43(1):101-9
Repetitive
transcranial magnetic stimulation increases the release of dopamine in the mesolimbic
and mesostriatal system.
Keck ME, Welt T, Muller MB, Erhardt A, Ohl F, Toschi N, Holsboer F, Sillaber
I.
Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, 80804, Munich,
Germany.
Mov Disord 2002 May;17(3):528-32
Therapeutic
efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation
in depressed patients with Parkinson's disease: an open study.
Dragasevic N, Potrebic A, Damjanovic A, Stefanova E, Kostic VS.
Institute of Neurology Clinical Center of Serbia, Medical School, Belgrade,
Yugoslavia.
Neurology 2002 Apr 23;58(8):1288-90
Improved
executive functioning following repetitive transcranial magnetic stimulation.
Moser DJ, Jorge RE, Manes F, Paradiso S, Benjamin ML, Robinson RG.
Department of Psychiatry, University of Iowa College of Medicine, Iowa City,
IA 52240, USA.
Biol Psychiatry 2002 Apr 15;51(8):687-90
Three
and six-month outcome following courses of either ECT or rTMS in a population
of severely depressed individuals--preliminary report.
Dannon PN, Dolberg OT, Schreiber S, Grunhaus L.
Psychiatry Division, ECT-TMS Unit, Chaim Sheba Medical Center, 52621 Tel
Hashomer, Israel.
Encephale 2002 Mar-Apr;28(2):169-75
[Transcranial
magnetic stimulation in depression]
[Article in French]
Saba G, Januel D, Glikman J.
Psychiatre, assistant, Unite de Recherche clinique, Secteur III, Service
du docteur Glikman, EPS de Ville Evrard, 5, rue du Docteur Delafontaine, 93200
Saint-Denis, France.
Arch Neurol 2002 Mar;59(3):413-7
Transcranial
magnetic stimulation of the cerebellum in essential tremor: a controlled study.
Gironell A, Kulisevsky J, Lorenzo J, Barbanoj M, Pascual-Sedano B, Otermin
P.
Servei de Neurologia, Hospital de Sant Pau, Av Sant Antoni Ma Claret 167,
08025
Nervenarzt 2001 Dec;72(12):932-8
[Contralateral
and ipsilateral repetitive transcranial magnetic stimulation in Parkinson patients]
[Article in German]
de Groot M, Hermann W, Steffen J, Wagner A, Grahmann F.
Klinik und Poliklinik fur Neurologie, Universitatsklinikum Leipzig, Liebigstrasse
22a, 04103 Leipzig.
Srp Arh Celok Lek 2001 Sep-Oct;129(9-10):235-8
[Effect
of slow repetitive transcranial magnetic stimulation on depression in patients
with Parkinson 's disease]
[Article in Serbo-Croatian (Cyrillic)]
Potrebic A, Dragasevic N, Svetel M, Kostic VS.
Institute of Psychiatry, Clinical Centre of Serbia, Belgrade.
J Affect Disord 2001 Sep;66(1):83-8
The
impact of repetitive transcranial magnetic stimulation on pituitary hormone
levels and cortisol in healthy subjects.
Evers S, Hengst K, Pecuch PW.
Department of Neurology, University of Munster, Albert-Schweitzer-Str. 33,
48129 Munster, Germany.
J Neurol 2001 Sep;248 Suppl 3:III48-52
Therapeutic
effect and mechanism of repetitive transcranial magnetic stimulation in Parkinson's
disease.
Shimamoto H, Takasaki K, Shigemori M, Imaizumi T, Ayabe M, Shoji H.
Shimamoto Neurosurgical Clinic, Kurume University School of Medicine, Ohnojo-city,
Fukuoka, Japan.
Psychopharmacol Bull 2001 Autumn;35(4):149-69
A
meta-analysis of repetitive transcranial magnetic stimulation in the treatment
of depression.
Holtzheimer PE 3rd, Russo J, Avery DH.
Department of Psychiatry and Behavioral Sciences, University of Washington
Medical Center, Harborview Medical Center, 325 Ninth Avenue, Box 359896, Seattle,
WA 98104, USA.
J Neurosci 2001 Aug 1;21(15):RC157
Repetitive
transcranial magnetic stimulation of the human prefrontal cortex induces dopamine
release in the caudate nucleus.
Strafella AP, Paus T, Barrett J, Dagher A.
Montreal Neurological Institute, McGill University, Montreal, Quebec, Canada
H3A 2B4.
Neurosci Lett 2001 May 11;303(3):165-8
Striatal
dopaminergic metabolism is increased by deep brain stimulation of the subthalamic
nucleus in 6-hydroxydopamine lesioned rats.
Meissner W, Reum T, Paul G, Harnack D, Sohr R, Morgenstern R, Kupsch A.
Department of Neurology, Charite Campus Virchow-Klinikum, Humboldt-University
Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Biol Psychiatry 2001 Jul 1;50(1):22-7
Acute
mood and thyroid stimulating hormone effects of transcranial magnetic stimulation
in major depression.
Szuba MP, O'Reardon JP, Rai AS, Snyder-Kastenberg J, Amsterdam JD, Gettes
DR, Wassermann E, Evans DL.
University of Pennsylvania, Department of Psychiatry, Philadelphia, Pennsylvania
19104, USA.
Brain Topogr 2000 Winter;13(2):135-44
Nonlinear
analysis of brain activity in magnetic influenced Parkinson patients.
Anninos PA, Adamopoulos AV, Kotini A, Tsagas N.
Dept. of Medicine, Demokrition University of Thrace, Alexandroupolis, Greece.
Nippon Rinsho. 2000 Oct;58(10):2120-4.
[Parkinson's disease and depression]
[Article in Japanese]
Kurokawa K, Yuasa T.
Department of Neurology, Kohnodai Hospital.
Up to 40% of cases of Parkinson's disease are associated with the occurrence
of depression. The symptoms of the patients' depressive state may be factors
such as significant weight change, insomnia or hypersomnia, psychomotor retardation,
fatigue or loss of energy, feelings of worthlessness or inappropriate guilt,
decreased concentration and indecisiveness, and recurrent thoughts of death
or suicidal ideation. Given these conditions, drugs prove ineffective in many
cases. Electroconvulsive therapy (ECT) has been reported to be beneficial in
cases of drug-resistant depression. ECT has also been applied to Parkinsonian
patients with depression and found to be effective with both depression and
the Parkinsonian symptom. Transcranial magnetic stimulation(TMS) has recently
been investigated for application in cases of depression and has become known
as a valuable tool for depression therapy. TMS is easily implemented even in
outpatient therapy. TMS will make a great contribution to the therapy of depression
with Parkinson's disease.
Int J Neurosci. 1998 Sep;95(3-4):255-69.
Reversal
of the bicycle drawing direction in Parkinson's disease by AC pulsed electromagnetic
fields.
Sandyk R.
Department of Neuroscience, Touro College, Dix Hills, NY 11746, USA.
Int J Neurosci. 1998 Feb;93(1-2):43-54.
Reversal
of a body image disorder (macrosomatognosia) in Parkinson's disease by treatment
with AC pulsed electromagnetic fields.
Sandyk R.
Department of Neuroscience, Institute for Biomedical Engineering and Rehabilitation
Services of Touro College, Dix Hills, NY 11746, USA.
Int J Neurosci. 1997 Nov;92(1-2):63-72.
Speech
impairment in Parkinson's disease is improved by transcranial application of
electromagnetic fields.
Sandyk R.
Department of Neuroscience, Touro College, Dix Hills, NY 11746, USA.
Int J Neurosci. 1997 Oct;91(3-4):189-97.
Treatment
with AC pulsed electromagnetic fields improves the response to levodopa in Parkinson's
disease.
Sandyk R.
Department of Neuroscience, Touro College, Dix Hills, NY 11746, USA.
Int J Neurosci. 1997 Sep;91(1-2):57-68.
Reversal
of cognitive impairment in an elderly parkinsonian patient by transcranial application
of picotesla electromagnetic fields.
Sandyk R.
Department of Neuroscience, Touro College, Dix Hills, NY 11746, USA.
Int J Neurosci. 1996 Mar;85(1-2):111-24.
Freezing
of gait in Parkinson's disease is improved by treatment with weak electromagnetic
fields.
Sandyk R.
NeuroCommunication Research Laboratories, Danbury, CT 06811, USA.
Int J Neurosci. 1995 Jun;82(3-4):255-68.
Reversal
of visuospatial deficit on the Clock Drawing Test in Parkinson's disease by
treatment with weak electromagnetic fields.
Sandyk R.
Panminerva Med. 1995 Jun;37(2):98-104.
A
physical mechanism in the treatment of neurologic disorders with externally
applied pico Tesla magnetic fields.
Jacobson JI, Yamanashi WS.
Institute of Theoretical Physics and Advanced Studies for Biophysical Research,
Jupiter, FL 33477-1418, USA.
Int J Neurosci. 1995 Mar;81(1-2):67-82.
Improvement
in short-term visual memory by weak electromagnetic fields in Parkinson's disease.
Sandyk R.
NeuroCommunication Research Laboratories, Danbury, CT 06811, USA.
Int J Neurosci. 1995 Mar;81(1-2):47-65.
Weak
electromagnetic fields reverse visuospatial hemi-inattention in Parkinson's
disease.
Sandyk R.
NeuroCommunication Research Laboratories, Danbury, CT 06811, USA.
Panminerva Med 1994 Dec;36(4):201-5
Pineal-hypothalamic
tract mediation of picotesla magnetic fields in the treatment of neurological
disorders.
Jacobson JI.
Institute of Theoretical Physics and Advanced Studies for Biophysical Research,
Jupiter, FL
Int J Neurosci. 1994 Nov;79(1-2):99-110.
A
drug naive parkinsonian patient successfully treated with weak electromagnetic
fields.
Sandyk R.
NeuroCommunication Research Laboratories, Danbury, CT 06811, USA.
Int J Neurosci. 1994 Jul;77(1-2):23-46.
Improvement
in word-fluency performance in Parkinson's disease by administration of electromagnetic
fields.
Sandyk R.
Neuro Communication Research Laboratories, Danbury, CT 06811.
Neurology 1994 May;44(5):892-8
Akinesia
in Parkinson's disease. II. Effects of subthreshold repetitive transcranial
motor cortex stimulation.
Pascual-Leone A, Valls-Sole J, Brasil-Neto JP, Cammarota A, Grafman J, Hallett
M.
Human Cortical Physiology Unit, National Institute of Neurological Disorders
and Stroke, National Institutes of Health, Bethesda, MD 20892.
Int J Neurosci. 1993 Jun;70(3-4):233-54.
Rapid
improvement of visuoperceptive functions by picoTesla range magnetic fields
in patients with Parkinson's disease.
Sandyk R, Iacono RP.
Int J Neurosci. 1993 May;70(1-2):85-96.
The
effects of external picoTesla range magnetic fields on the EEG in Parkinson's
disease.
Sandyk R, Derpapas K.
NeuroCommunication Research Laboratories, Danbury, CT 06811.
Int J Neurosci. 1993 Mar-Apr;69(1-4):167-83.
Further
observations on the unique efficacy of picoTesla range magnetic fields in Parkinson's
disease.
Sandyk R, Derpapas K.
NeuroCommunication Research Laboratories, Danbury, CT 06811.
Int J Neurosci. 1993 Jan;68(1-2):85-91.
Weak
magnetic fields antagonize the effects of melatonin on blood glucose levels
in Parkinson's disease.
Sandyk R.
Department of Medical Physics, University of Thrace, Alexandroupolis, Greece.
Int J Neurosci. 1992 Oct;66(3-4):209-35.
Magnetic
fields in the therapy of parkinsonism.
Sandyk R.
NeuroCommunication Research Laboratories, Danbury, CT 06811.
Int J Neurosci 1992 Mar;63(1-2):141-50
Magnetic
fields in the treatment of Parkinson's disease.
Sandyk R, Anninos PA, Tsagas N, Derpapas K.
Democrition University of Thrace, Department of Medical Physics and Polytechnic
School, Alexandroupolis and Xanthi, Greece.